These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 32579995

  • 1. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease.
    Toita R, Kang JH.
    Toxicol Lett; 2020 Oct 10; 332():1-6. PubMed ID: 32579995
    [Abstract] [Full Text] [Related]

  • 2. Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
    Heintz MM, McRee R, Kumar R, Baldwin WS.
    PLoS One; 2020 Oct 10; 15(3):e0229896. PubMed ID: 32155178
    [Abstract] [Full Text] [Related]

  • 3. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice.
    Susutlertpanya W, Wakuda H, Otani N, Kuramoto T, Li L, Kuranari M, Sekiguchi A, Kudo H, Uchida T, Imai H, Uemura N.
    Life Sci; 2019 Jul 01; 228():251-257. PubMed ID: 31078545
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH).
    Yasuda D, Torii H, Shimizu R, Hiraoka Y, Kume N.
    Biol Pharm Bull; 2020 Jul 01; 43(4):616-618. PubMed ID: 32238704
    [Abstract] [Full Text] [Related]

  • 6. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    Min-DeBartolo J, Schlerman F, Akare S, Wang J, McMahon J, Zhan Y, Syed J, He W, Zhang B, Martinez RV.
    PLoS One; 2019 Jul 01; 14(12):e0226854. PubMed ID: 31891606
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease.
    Horas H Nababan S, Nishiumi S, Kawano Y, Kobayashi T, Yoshida M, Azuma T.
    Arch Biochem Biophys; 2017 Jun 01; 623-624():64-75. PubMed ID: 28456640
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Deletion of TRPC3 or TRPC6 Fails to Attenuate the Formation of Inflammation and Fibrosis in Non-alcoholic Steatohepatitis.
    Nishiyama K, Toyama C, Kato Y, Tanaka T, Nishimura A, Nagata R, Mori Y, Nishida M.
    Biol Pharm Bull; 2021 Jun 01; 44(3):431-436. PubMed ID: 33642551
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. One Week of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver.
    Sugasawa T, Ono S, Yonamine M, Fujita SI, Matsumoto Y, Aoki K, Nakano T, Tamai S, Yoshida Y, Kawakami Y, Takekoshi K.
    Int J Mol Sci; 2021 May 29; 22(11):. PubMed ID: 34072586
    [Abstract] [Full Text] [Related]

  • 18. Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis.
    Suga T, Yamaguchi H, Ogura J, Shoji S, Maekawa M, Mano N.
    Toxicol Appl Pharmacol; 2019 Sep 15; 379():114664. PubMed ID: 31306673
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of hepatic integrin αvβ3 expression in non-alcoholic steatohepatitis (NASH) model mouse by 18F-FPP-RGD2 PET.
    Rokugawa T, Konishi H, Ito M, Iimori H, Nagai R, Shimosegawa E, Hatazawa J, Abe K.
    EJNMMI Res; 2018 May 31; 8(1):40. PubMed ID: 29855729
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
    Fengler VH, Macheiner T, Kessler SM, Czepukojc B, Gemperlein K, Müller R, Kiemer AK, Magnes C, Haybaeck J, Lackner C, Sargsyan K.
    PLoS One; 2016 May 31; 11(5):e0155163. PubMed ID: 27167736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.